We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Compelling Reasons to Hold on to Marsh & McLennan Stock
Read MoreHide Full Article
Marsh & McLennan Companies, Inc. (MMC - Free Report) is aided by sustained revenue growth, a commendable acquisition strategy, rate hikes and sound financial position.
MMC Stock’s Zacks Rank & Price Rally
Marsh & McLennan currently carries a Zacks Rank #3 (Hold).
The stock has gained 8.4% year to date compared with the industry’s 7.3% growth. The Zacks Finance sector and the S&P 500 composite have declined 7.6% and 14.1%, respectively, in the said time frame.
Image Source: Zacks Investment Research
Robust Growth Prospects of MMC Stock
The Zacks Consensus Estimate for Marsh & McLennan’s 2025 earnings is pegged at $9.57 per share, indicating a 8.8% increase from the 2024 figure. The estimate for revenues is $26.9 billion, implying 9.9% growth from the prior-year number.
The consensus estimate for 2026 earnings is pegged at $10.45 per share, indicating 9.1% growth from the 2025 estimate. The same for revenues is $28.4 billion, which indicates a rise of 5.5% from the prior-year estimate.
MMC’s Robust Earnings Surprise History
MMC boasts an impressive surprise history. Its earnings outpaced estimates in each of the trailing four quarters, the average surprise being 3.13%.
Solid Return on Equity of MMC Stock
The return on equity for Marsh & McLennan is currently 32.6%, which is higher than the industry’s average of 29.5%. The figure substantiates the company’s efficiency in utilizing shareholders’ funds.
Business Tailwinds of MMC
Marsh & McLennan’s revenue momentum continues to be fueled by robust performance across both its Risk and Insurance Services and Consulting divisions. Since 2010, the company has consistently grown its top line, with the sole exception of 2015. For 2025, management anticipates achieving underlying revenue growth in the mid-single digits.
The Risk and Insurance Services segment is experiencing positive traction, driven by strong new business generation, rising renewal rates and favorable trends in insurance and reinsurance pricing, bolstered by an expanding global economy. During 2024, the segment completed 10 acquisitions, some of which were those of Fisher Brown Bottrell Insurance, AmeriStar Agency, The Horton Group, McGriff and Acumen Solutions Group.
Meanwhile, the Consulting division continues to thrive, supported by sustained demand for its health, wealth and career advisory services. This segment also broadened its capabilities through seven strategic acquisitions over the same time frame.
Marsh & McLennan remains committed to an active acquisition strategy, regularly pursuing opportunities across its business segments to strengthen its global presence, tap into new markets and enhance its existing service offerings. In 2024 alone, the company invested $8.5 billion in acquisitions. A notable recent transaction was the acquisition of Pennsylvania-based Arthur Hall Insurance, which delivers specialized expertise in both the commercial and personal insurance lines to clients nationwide.
Underpinning its growth and acquisition ambitions is Marsh & McLennan’s solid financial position. The company benefits from healthy cash reserves and strong cash flow generation, enabling it not only to pursue strategic investments but also to consistently return value to shareholders through dividends and share repurchases. Its current dividend yield of 1.4% surpasses the industry average of 1%.
MMC’s Key Risks
The company’s operating expenses have steadily risen in the past few years. The metric escalated 6.8% in 2024, due to higher salaries and incentives. Meanwhile, long-term debt grew from $11.8 billion in 2023 to $19.4 billion by 2024-end. A debt-laden balance sheet induces an increase in interest expenses, which escalated 21.1% in 2024. Management forecasts the metric at around $246 million for the first quarter of 2025. Despite deleveraging efforts, rising costs and debt remain concerns, potentially pressuring margins.
EverQuote’s earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 160.73%. The Zacks Consensus Estimate for EVER’s 2025 earnings indicates a 36.4% rise while the estimate for revenues implies an improvement of 25.2% from the respective prior-year figures.
The consensus mark for EVER’s earnings has moved 6.2% north in the past 30 days. Shares of EverQuote have gained 8.4% year to date.
Brown & Brown’s earnings surpassed estimates in each of the last four quarters, the average surprise being 8.18%. The Zacks Consensus Estimate for BRO’s 2025 earnings indicates a 9.1% rise while the estimate for revenues implies an improvement of 8.4% from the respective prior-year figures.
The consensus mark for BRO’s earnings has moved 0.2% north in the past 30 days. Shares of Brown & Brown have gained 10.6% year to date.
Progressive’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 18.49%. The Zacks Consensus Estimate for PGR’s 2025 earnings indicates a 9.8% rise while the estimate for revenues implies an improvement of 16.1% from the respective prior-year figures.
The consensus mark for PGR’s earnings has moved up 0.6% in the past 30 days. Shares of Progressive have gained 7% year to date.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Compelling Reasons to Hold on to Marsh & McLennan Stock
Marsh & McLennan Companies, Inc. (MMC - Free Report) is aided by sustained revenue growth, a commendable acquisition strategy, rate hikes and sound financial position.
MMC Stock’s Zacks Rank & Price Rally
Marsh & McLennan currently carries a Zacks Rank #3 (Hold).
The stock has gained 8.4% year to date compared with the industry’s 7.3% growth. The Zacks Finance sector and the S&P 500 composite have declined 7.6% and 14.1%, respectively, in the said time frame.
Image Source: Zacks Investment Research
Robust Growth Prospects of MMC Stock
The Zacks Consensus Estimate for Marsh & McLennan’s 2025 earnings is pegged at $9.57 per share, indicating a 8.8% increase from the 2024 figure. The estimate for revenues is $26.9 billion, implying 9.9% growth from the prior-year number.
The consensus estimate for 2026 earnings is pegged at $10.45 per share, indicating 9.1% growth from the 2025 estimate. The same for revenues is $28.4 billion, which indicates a rise of 5.5% from the prior-year estimate.
MMC’s Robust Earnings Surprise History
MMC boasts an impressive surprise history. Its earnings outpaced estimates in each of the trailing four quarters, the average surprise being 3.13%.
Solid Return on Equity of MMC Stock
The return on equity for Marsh & McLennan is currently 32.6%, which is higher than the industry’s average of 29.5%. The figure substantiates the company’s efficiency in utilizing shareholders’ funds.
Business Tailwinds of MMC
Marsh & McLennan’s revenue momentum continues to be fueled by robust performance across both its Risk and Insurance Services and Consulting divisions. Since 2010, the company has consistently grown its top line, with the sole exception of 2015. For 2025, management anticipates achieving underlying revenue growth in the mid-single digits.
The Risk and Insurance Services segment is experiencing positive traction, driven by strong new business generation, rising renewal rates and favorable trends in insurance and reinsurance pricing, bolstered by an expanding global economy. During 2024, the segment completed 10 acquisitions, some of which were those of Fisher Brown Bottrell Insurance, AmeriStar Agency, The Horton Group, McGriff and Acumen Solutions Group.
Meanwhile, the Consulting division continues to thrive, supported by sustained demand for its health, wealth and career advisory services. This segment also broadened its capabilities through seven strategic acquisitions over the same time frame.
Marsh & McLennan remains committed to an active acquisition strategy, regularly pursuing opportunities across its business segments to strengthen its global presence, tap into new markets and enhance its existing service offerings. In 2024 alone, the company invested $8.5 billion in acquisitions. A notable recent transaction was the acquisition of Pennsylvania-based Arthur Hall Insurance, which delivers specialized expertise in both the commercial and personal insurance lines to clients nationwide.
Underpinning its growth and acquisition ambitions is Marsh & McLennan’s solid financial position. The company benefits from healthy cash reserves and strong cash flow generation, enabling it not only to pursue strategic investments but also to consistently return value to shareholders through dividends and share repurchases. Its current dividend yield of 1.4% surpasses the industry average of 1%.
MMC’s Key Risks
The company’s operating expenses have steadily risen in the past few years. The metric escalated 6.8% in 2024, due to higher salaries and incentives. Meanwhile, long-term debt grew from $11.8 billion in 2023 to $19.4 billion by 2024-end. A debt-laden balance sheet induces an increase in interest expenses, which escalated 21.1% in 2024. Management forecasts the metric at around $246 million for the first quarter of 2025. Despite deleveraging efforts, rising costs and debt remain concerns, potentially pressuring margins.
Stocks to Consider
Some better-ranked stocks in the insurance space are EverQuote, Inc. (EVER - Free Report) , Brown & Brown, Inc. (BRO - Free Report) and The Progressive Corporation (PGR - Free Report) . While EverQuote sports a Zacks Rank #1 (Strong Buy), Brown & Brown and Progressive carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
EverQuote’s earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 160.73%. The Zacks Consensus Estimate for EVER’s 2025 earnings indicates a 36.4% rise while the estimate for revenues implies an improvement of 25.2% from the respective prior-year figures.
The consensus mark for EVER’s earnings has moved 6.2% north in the past 30 days. Shares of EverQuote have gained 8.4% year to date.
Brown & Brown’s earnings surpassed estimates in each of the last four quarters, the average surprise being 8.18%. The Zacks Consensus Estimate for BRO’s 2025 earnings indicates a 9.1% rise while the estimate for revenues implies an improvement of 8.4% from the respective prior-year figures.
The consensus mark for BRO’s earnings has moved 0.2% north in the past 30 days. Shares of Brown & Brown have gained 10.6% year to date.
Progressive’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 18.49%. The Zacks Consensus Estimate for PGR’s 2025 earnings indicates a 9.8% rise while the estimate for revenues implies an improvement of 16.1% from the respective prior-year figures.
The consensus mark for PGR’s earnings has moved up 0.6% in the past 30 days. Shares of Progressive have gained 7% year to date.